Dr Soumya Swaminathan, who is the chief scientist at the World Health Organization (WHO) on Thursday, said that nearly 2 billion doses of the COVID-19 vaccine would be ready by the end of next year.

TOP INSIGHT
Out of 100 COVID-19 Vaccine candidates, AstraZeneca's vaccine developed could provide protection against the disease for one year.
Read More..
There are currently over 100 vaccines in various stages of trials.
AstraZeneca’s COVID-19 vaccine candidate developed by researchers from Oxford University will likely provide protection against the disease for one year, the British drug maker’s CEO told Belgian radio station Bel RTL this week.
Oxford University last month announced the start of a Phase II/III UK trial of the vaccine, named AZD1222 (formerly known as ChAdOx1 nCoV-19), in about 10,000 adult volunteers. Other late-stage trials are due to begin in a number of countries.
MEDINDIA

Email










